首页|First Affiliated Hospital of Nanchang University Reports Findings in Artificial Intelligence (Heterogeneity of computational pathomic signature predicts drug resistance and intra-tumor heterogeneity of ovarian cancer)
First Affiliated Hospital of Nanchang University Reports Findings in Artificial Intelligence (Heterogeneity of computational pathomic signature predicts drug resistance and intra-tumor heterogeneity of ovarian cancer)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Artificial Intelligence is the subject of a report. According to newsreporting originating from Nanchang, People’s Republic of China, by NewsRx correspondents, researchstated, “Chemotherapy resistance is the main cause of ovarian cancer progression and even death. However,there are no clear indicators for predicting the risk of drug resistance in patients.”
NanchangPeople’s Republic of ChinaAsiaArtificial IntelligenceCancerDrug ResistanceDrugs and TherapiesEmerging TechnologiesGeneticsGynecologyHealth and MedicineMachine LearningOncologyOvarian CancerRisk and PreventionWomen’s Health
NETL
NSTL
